PHARMALEX
LIVE

Serial Number

79288155

Owner

PharmaLex GmbH

Attorney

Mark J. Liss

Filing Date

May 19, 2020

Add to watchlist:

No watchlists yet
View on USPTO

PHARMALEX Trademark

Serial Number: 79288155 • Registration: 6522578

PHARMALEX is a trademark filed by PharmaLex GmbH on May 19, 2020. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PharmaLex GmbH (10 trademarks)

Bahnstrasse 42-46

Entity Type: 99

Trademark Details

Filing Date

May 19, 2020

Registration Date

October 19, 2021

Published for Opposition

August 3, 2021

Goods & Services

Educational services, namely, conducting online exhibitions, displays and exhibits in the field of pharmacovigilance, biosimilars, medical products, medical services, clinical data review, chemistry data evaluation, scientific research, and laboratory research in the field of pharmaceuticals, medicines and medical products; educational services, namely, conducting classes, seminars, conferences, and workshops in the field of pharmacovigilance, clinical data review, chemistry data evaluation, scientific research, and laboratory research in the field of pharmaceuticals, biosimilars, medicines and medical products and distribution of training material in connection therewith; providing of training services, for others, in the field of pharmacovigilance, clinical data review, chemistry data evaluation, scientific research, and laboratory research in the field of pharmaceuticals, biosimilars, medicines and medical products; providing of employee training services, for others in the field of pharmaceutical products, biosimilars, medical products and medical services

Advertising services; business management; business administration services; providing office functions

Legal services

Medical services; veterinary services

Scientific and technological services and research and design relating thereto, namely, new product design and scientific research in the field of pharmacovigilance, clinical data review, chemistry data evaluation; Scientific research and laboratory research, all in the field of pharmaceuticals, medicines and medical products; industrial analysis and research services, namely, laboratory research services relating to pharmaceuticals, pharmaceutical research services, and research and development of new products for others

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 15, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 18, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 17, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 30, 2022 FICS
FINAL DISPOSITION PROCESSED
Mar 30, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 19, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 19, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 3, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 3, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Aug 1, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 14, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 14, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 14, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 25, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 25, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 25, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 25, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 25, 2021 CNEA
ASSIGNED TO EXAMINER
May 19, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 26, 2021 TROA
REFUSAL PROCESSED BY IB
Sep 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 5, 2020 RFCS
REFUSAL PROCESSED BY MPU
Aug 28, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 21, 2020 RFCR
NON-FINAL ACTION WRITTEN
Aug 20, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 17, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 30, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 26, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 25, 2020 REPR